Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation

被引:82
作者
Luthi-Carter, R
Apostol, BL
Dunah, AW
DeJohn, MM
Farrell, LA
Bates, GP
Young, AB
Standaert, DG
Thompson, LM
Cha, JHJ
机构
[1] MassGen Inst Neurodegenerat Dis, Charlottetown, MA 02129 USA
[2] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA
[3] Guys Hosp, GKT Sch Med, Div Med & Mol Genet, London SE1 9RT, England
关键词
D O I
10.1016/j.nbd.2003.08.024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We analyzed NMDA receptor subunit mRNAs, proteins, and anchoring proteins in mice transgenic for exon 1 of the HD gene. R6/2 mice had decreased levels of mRNAs encoding epsilon1 and epsilon2 NMDA receptor subunits (mouse orthologs of rat NR2A and NR2B subunits), but not the zeta1 subunit (mouse ortholog of NR1), as assessed by gene expression profiling and Northern blotting. In situ hybridization resolved mRNA decreases spatially to the CA1 field of hippocampus. Western blotting revealed decreases in plasma membrane-associated 81 and epsilon2 subunits in hippocampus, and decreases in plasma membrane-associated I subunit in cortex and hippocampus. In addition, PSD-95 and alpha-actinin-2, proteins essential for anchoring NMDA receptors, were decreased. Finally, we found a decreased level of tyrosine-phosphorylated epsilon1 subunit, another determinant of NMDA receptor trafficking, in R6/2 hippocampus. Taken together, these data demonstrate multiple levels of NMDA receptor dysregulation, including abnormalities in mRNA expression levels, receptor stoichiometry, protein phosphorylation, and receptor trafficking. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:624 / 636
页数:13
相关论文
共 66 条
[1]   CAG EXPANSION AFFECTS THE EXPRESSION OF MUTANT HUNTINGTIN IN THE HUNTINGTONS-DISEASE BRAIN [J].
ARONIN, N ;
CHASE, K ;
YOUNG, C ;
SAPP, E ;
SCHWARZ, C ;
MATTA, N ;
KORNREICH, R ;
LANDWEHRMEYER, B ;
BIRD, E ;
BEAL, MF ;
VONSATTEL, JP ;
SMITH, T ;
CARRAWAY, R ;
BOYCE, FM ;
YOUNG, AB ;
PENNEY, JB ;
DIFIGLIA, M .
NEURON, 1995, 15 (05) :1193-1201
[2]   Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease - An in situ hybridization study [J].
Arzberger, T ;
Krampfl, K ;
Leimgruber, S ;
Weindl, A .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (04) :440-454
[3]  
AUGOOD SJ, 1994, IN SITU HYBRIDIZATIO, P81
[4]  
Ausubel FM., 1998, CURRENT PROTOCOLS MO
[5]   REPLICATION OF THE NEUROCHEMICAL CHARACTERISTICS OF HUNTINGTONS-DISEASE BY QUINOLINIC ACID [J].
BEAL, MF ;
KOWALL, NW ;
ELLISON, DW ;
MAZUREK, MF ;
SWARTZ, KJ ;
MARTIN, JB .
NATURE, 1986, 321 (6066) :168-171
[6]   Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice [J].
Bibb, JA ;
Yan, Z ;
Svenningsson, P ;
Snyder, GL ;
Pieribone, VA ;
Horiuchi, A ;
Nairn, AC ;
Messer, A ;
Greengard, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) :6809-6814
[7]  
Carter RJ, 2000, MOVEMENT DISORD, V15, P925, DOI 10.1002/1531-8257(200009)15:5<925::AID-MDS1025>3.0.CO
[8]  
2-Z
[9]   Loss of normal huntingtin function: new developments in Huntington's disease research [J].
Cattaneo, E ;
Rigamonti, D ;
Goffredo, D ;
Zuccato, C ;
Squitieri, F ;
Sipione, S .
TRENDS IN NEUROSCIENCES, 2001, 24 (03) :182-188
[10]   NMDA receptor function in mouse models of Huntington disease [J].
Cepeda, C ;
Ariano, MA ;
Calvert, CR ;
Flores-Hernández, J ;
Chandler, SH ;
Leavitt, BR ;
Hayden, MR ;
Levine, MS .
JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 66 (04) :525-539